Table 1.
Year(s) of sera collection | Source of sample population* |
Serologic test modalities* |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Number of articles reporting on country | General population | Patients at a healthcare facility | Not reported | HI | IP | NT | CF | ELISA | ||
Africa | ||||||||||
West/Central Africa | ||||||||||
Angola38 83 | 2 | 1960, 1971–1972 | X | X | X | X | ||||
Benin66 | 1 | 1967 | X | X | ||||||
Burkina Faso31 33 | 2 | 1963–1964, 1979 | X | X | X | |||||
Cameroon45 46 63 90 | 4 | 1963–1966, 1971–1972, 1984 | X | X | X | |||||
Central African Republic28 32 34–37 40 88 97 | 9 | 1954†, 1961–1967, 1975, 1979 | X | X | X | X | X | |||
Chad88 | 1 | 1954† | X | X | ||||||
Côte d'Ivoire21 24 44 92 | 4 | 1963–1965, 1969, 1977, 1999 | X | X | X | X | X | X | ||
Gabon66 78 98 | 3 | 1967, 1975, 1979–1980 | X | X | X | |||||
Guinea-Bissau43 | 1 | 1964–1965 | X | X | ||||||
Liberia47 66 | 2 | 1967, 1981–1982 | X | X | ||||||
Mali66 | 1 | 1964–1967 | X | X | ||||||
Niger66 | 1 | 1965 | X | X | ||||||
Nigeria5 26 27 29 50 62 66 68 69 84–86 | 12 | 1951–1953, 1955, 1964–1975, 1980 | X | X | X | X | X | X | ||
Republic of the Congo88 | 1 | 1954† | X | X | ||||||
Senegal22 25 65 87 91 | 5 | 1962, 1965–1966, 1970–1975, 1988–1990 | X | X | X | X | X | X | ||
Sierra Leone93 | 1 | 1972 | X | X | ||||||
Togo66 | 1 | 1964–1966 | X | X | ||||||
Africa, other | ||||||||||
Burundi94 | 1 | 1980–1982 | X | X | ||||||
Djibouti30 | 1 | 1991–1992 | X | X | ||||||
Egypt101 | 1 | 1954 | X | X | X | |||||
Ethiopia74 95 99 104 | 4 | 1961–1964, 1966, 1971 | X | X | X | |||||
Kenya64 72 76 104 | 4 | 1961–1962, 1966–1969 | X | X | X | X | ||||
Madagascar70 71 | 2 | 1977, 1986 | X | X | X | |||||
Mozambique82 | 1 | 1957 | X | X | ||||||
Republic of Seychelles80 | 1 | 1970† | X | X | ||||||
Somalia74 76 | 2 | 1966, 1969 | X | X | ||||||
Sudan23 | 1 | 1976 | X | X | X | |||||
Tanzania76 100 104 | 3 | 1945–1948, 1961–1962, 1967–1969 | X | X | X | X | ||||
Uganda67 75–77 81 96 100 104 | 8 | 1945–1948, 1961–1962, 1967–1969, 1970, 1984 | X | X | X | X | ||||
Asia | ||||||||||
South Asia | ||||||||||
India103 | 1 | 1952 | X | X | ||||||
Pakistan51 | 1 | 1979–1980 | X | X | ||||||
East Asia | ||||||||||
Hong Kong79 | 1 | 1973–1977 | X | X | ||||||
Southeast Asia | ||||||||||
Indonesia8 42 48 | 3 | 1973, 1977–1978 | X | X | X | X | ||||
Malaysia49 89 102 | 3 | 1953–1954, 1996–1997 | X | X | X | X | ||||
Philippines73 | 1 | 1953 | X | X | ||||||
Thailand89 | 1 | 1954 | X | X | ||||||
Vietnam89 | 1 | 1954 | X | X | ||||||
Europe | ||||||||||
Spain39 41 | 2 | 1977†, 1980 | X | X | X |
*Marked if applicable to one or more studies reporting on country.
†Year of article publication for articles not reporting year(s) of sera collection.
CF, complement fixation test; ELISA, enzyme-linked immunosorbent assay; HI, haemagglutination inhibition assay; IP, intracerebral mouse-protection test; NT, viral neutralisation antibody test (plaque reduction neutralisation test or microneutralisation).